We are committed to developing innovative therapies for life-threatening diseases

Building on our heritage in antiviral care, we are using all our expertise and resources to support the fight against COVID-19

Healthcare professionals

Access up-to-date information about treating COVID-19, including clinical data, treatment administration and supply.

Healthcare professional information

Members of the public

Find out about Gilead’s response to COVID-19.

Public information

COVID-19, coronavirus disease 2019.

This website has been designed, built and funded by Gilead. Commentary and other materials – including external links – posted on this site are not intended to amount to advice on which reliance should be placed. Any information or decision with regards to treatment with Gilead medicines should be discussed with your healthcare professional.

▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. For Great Britain and Northern Ireland, reporting forms and information can be found at coronavirus-yellowcard.mhra.gov.uk or via the Yellow Card app (download from the Apple App Store or Google Play Store). For Ireland, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971. Adverse events should also be reported to Gilead to safety_FC@gilead.com or +44 (0) 1223 897500. By reporting side effects, you can help provide more information on the safety of this medicine.

Date of preparation: 09/21 Section job code: UK-VKY-0043

DISCLAIMER: This link will take you to an external, third-party website. Gilead is not responsible for and does not control the content of this third-party website

Cancel Follow Link